Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0L0RX
|
|||
Former ID |
DIB014993
|
|||
Drug Name |
ABX-101
|
|||
Synonyms |
Anticancer antibody (1), Abxign
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Investigative | [1] | |
Company |
Abxign Inc
|
|||
Structure |
Download2D MOL |
|||
Formula |
C23H27N3O4
|
|||
Canonical SMILES |
CCCCC=CC(=O)NCC1CN(C(=O)O1)C2=CC3=C(COCC4=CC=CN43)C=C2
|
|||
InChI |
1S/C23H27N3O4/c1-2-3-4-5-8-22(27)24-13-20-14-26(23(28)30-20)18-10-9-17-15-29-16-19-7-6-11-25(19)21(17)12-18/h5-12,20H,2-4,13-16H2,1H3,(H,24,27)/b8-5+/t20-/m0/s1
|
|||
InChIKey |
UTDQLUHWNVCYMK-FKIZTMCRSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
References | Top | |||
---|---|---|---|---|
REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.